Company Overview
Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a highly energetic and curious Co-op to join our growing regulatory team from January through June 2025. The co-op will be responsible for supporting regulatory strategy while learning about the role of regulatory affairs in biotherapeutics development. The co-op will be involved in setting and executing a regulatory strategy for novel gene editing programs. This may include activities like regulatory precedent research, regulatory interaction planning, and submissions preparation. The co-op will also have a chance to learn about and support other areas of regulatory affairs including CMC, labeling, and operations.
Responsibilities:
Qualifications: